SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the September 2024 quarter moved up 38.91% to Rs. 12926.00 millions as compared to Rs. 9305.00 millions during the corresponding quarter last year.Handsome Net Profit growth of 83.54% reported above the corresponding previous quarter figure of Rs. 6611.00 millions to Rs. 3602.00 millions.Operating profit for the quarter ended September 2024 rose to 8421.00 millions as compared to 4670.00 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 12926.00 9305.00 38.91 25295.00 19788.00 27.83 35689.00 23510.00 51.80
Other Income 514.00 247.00 108.10 912.00 393.00 132.06 1047.00 855.00 22.46
PBIDT 8421.00 4670.00 80.32 16449.00 9853.00 66.94 17417.00 9302.00 87.24
Interest 30.00 30.00 0.00 74.00 62.00 19.35 145.00 86.00 68.60
PBDT 8391.00 4640.00 80.84 16375.00 9791.00 67.25 17272.00 9216.00 87.41
Depreciation 422.00 400.00 5.50 826.00 799.00 3.38 1719.00 1509.00 13.92
PBT 7969.00 4240.00 87.95 15549.00 8992.00 72.92 15553.00 7707.00 101.80
TAX 1358.00 638.00 112.85 2575.00 1337.00 92.60 2487.00 1336.00 86.15
Deferred Tax -120.00 -115.00 4.35 -227.00 -254.00 -10.63 -361.00 5.00 -7320.00
PAT 6611.00 3602.00 83.54 12974.00 7655.00 69.48 13066.00 6371.00 105.09
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 365.00 -1.92
PBIDTM(%) 65.15 50.19 29.81 65.03 49.79 30.60 48.80 39.57 23.34

Natco Pharma Share Price

1208.75 34.75 (2.96%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×